TW200616616A - Paclitaxel aqueous injection solution and methods for preparing the same - Google Patents
Paclitaxel aqueous injection solution and methods for preparing the sameInfo
- Publication number
- TW200616616A TW200616616A TW094118128A TW94118128A TW200616616A TW 200616616 A TW200616616 A TW 200616616A TW 094118128 A TW094118128 A TW 094118128A TW 94118128 A TW94118128 A TW 94118128A TW 200616616 A TW200616616 A TW 200616616A
- Authority
- TW
- Taiwan
- Prior art keywords
- paclitaxel
- pharmaceutical composition
- preparing
- methods
- same
- Prior art date
Links
- 229930012538 Paclitaxel Natural products 0.000 title abstract 4
- 229960001592 paclitaxel Drugs 0.000 title abstract 4
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 4
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000243 solution Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000004359 castor oil Substances 0.000 abstract 1
- 235000019438 castor oil Nutrition 0.000 abstract 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/995,262 US7361683B2 (en) | 2004-11-24 | 2004-11-24 | Paclitaxel aqueous injection solution and methods for preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200616616A true TW200616616A (en) | 2006-06-01 |
| TWI303566B TWI303566B (en) | 2008-12-01 |
Family
ID=34933891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094118128A TWI303566B (en) | 2004-11-24 | 2005-06-02 | Paclitaxel aqueous injection solution and methods for preparing the same |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7361683B2 (zh) |
| EP (1) | EP1666069B1 (zh) |
| JP (1) | JP4805599B2 (zh) |
| AT (1) | ATE405292T1 (zh) |
| DE (1) | DE602005009110D1 (zh) |
| TW (1) | TWI303566B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE539761T1 (de) * | 2006-06-29 | 2012-01-15 | Arigen Pharmaceuticals Inc | Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion |
| GB2445746A (en) * | 2007-01-17 | 2008-07-23 | Texcontor Ets | Use of carbonated water as a solvent for freeze drying, and method of purification comprising dissolution of material in carbonated water and freeze drying |
| DE102007021862A1 (de) * | 2007-05-10 | 2008-11-13 | Merck Patent Gmbh | Wässrige pharmazeutische Zubereitung |
| CN101396354B (zh) * | 2007-09-30 | 2010-12-01 | 江苏恒瑞医药股份有限公司 | 一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用 |
| CN104203251B (zh) * | 2012-03-22 | 2017-05-31 | 盐水港精糖株式会社 | 内包紫杉醇单糖苷和/或紫杉萜单糖苷的脂质体的制造方法 |
| WO2014028704A1 (en) * | 2012-08-15 | 2014-02-20 | Yung Shin Pharm. Ind. Co., Ltd. | Stable pharmaceutical formulation of cabazitaxel |
| TW201420130A (zh) * | 2012-09-26 | 2014-06-01 | Neochemir Inc | 溶解有二氧化碳之液狀藥劑及其投藥方法 |
| WO2015106094A1 (en) * | 2014-01-10 | 2015-07-16 | Atossa Genetics Inc. | Transpapillary methods and compositions for diagnosing and treating breast conditions |
| CN114588270A (zh) | 2015-09-16 | 2022-06-07 | Dfb索里亚有限责任公司 | 包含紫杉烷类纳米颗粒的组合物及其用途 |
| WO2018170196A1 (en) | 2017-03-15 | 2018-09-20 | Dfb Soria, Llc | Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes |
| EP3765035A4 (en) | 2018-03-16 | 2021-10-27 | DFB Soria, LLC | TOPICAL THERAPY FOR TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) AND ETERNAL CANCER USING TAXANNANO PARTICLES |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994012031A1 (en) * | 1992-11-27 | 1994-06-09 | Napro Biotherapeutics, Inc. | Injectable composition |
| TW406020B (en) | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| JP4000426B2 (ja) * | 1996-05-08 | 2007-10-31 | 株式会社大塚製薬工場 | 輸液製剤 |
| JP3375518B2 (ja) * | 1997-06-23 | 2003-02-10 | 清水製薬株式会社 | 注射剤 |
| JP2003201242A (ja) * | 2001-12-28 | 2003-07-18 | Shimizu Pharmaceutical Co Ltd | 重曹リンゲル様液剤 |
-
2004
- 2004-11-24 US US10/995,262 patent/US7361683B2/en not_active Expired - Fee Related
-
2005
- 2005-02-23 EP EP05003915A patent/EP1666069B1/en not_active Not-in-force
- 2005-02-23 DE DE602005009110T patent/DE602005009110D1/de active Active
- 2005-02-23 AT AT05003915T patent/ATE405292T1/de not_active IP Right Cessation
- 2005-04-15 JP JP2005118226A patent/JP4805599B2/ja not_active Expired - Fee Related
- 2005-06-02 TW TW094118128A patent/TWI303566B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE405292T1 (de) | 2008-09-15 |
| US20060111432A1 (en) | 2006-05-25 |
| DE602005009110D1 (de) | 2008-10-02 |
| EP1666069B1 (en) | 2008-08-20 |
| JP2006143699A (ja) | 2006-06-08 |
| US7361683B2 (en) | 2008-04-22 |
| JP4805599B2 (ja) | 2011-11-02 |
| TWI303566B (en) | 2008-12-01 |
| EP1666069A1 (en) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200616616A (en) | Paclitaxel aqueous injection solution and methods for preparing the same | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| UA92470C2 (ru) | Стабильный при хранении инфузионный раствор дигидроптеридинонов | |
| EA200870060A1 (ru) | Эмульсия бутилфталида для внутривенного введения и ее применение | |
| ZA200901075B (en) | Pharmaceutical composition | |
| BRPI0508540A8 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| TNSN06411A1 (en) | Pyrimidine urea derivatives as kinase inhibitors | |
| JP2005343897A5 (zh) | ||
| TNSN07419A1 (en) | Methods for treating drug resistant cancer | |
| HRP20140215T1 (hr) | Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika | |
| TW200635616A (en) | Organic compounds | |
| MXPA03011480A (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral. | |
| MXPA04011990A (es) | Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo. | |
| TW200628468A (en) | Bicyclononene derivatives | |
| ATE376834T1 (de) | Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase | |
| WO2006071564A3 (en) | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents | |
| BRPI0518554A2 (pt) | uso de um inibidor de pde3 | |
| UA93365C2 (ru) | Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты) | |
| WO2008001204A3 (en) | Transdermal compositions of pramipexole having enhanced permeation properties | |
| EA200701805A1 (ru) | Состав аэрозоля для дозирующих ингаляторов под давлением | |
| EA200701741A1 (ru) | Композиция, содержащая окаперидон | |
| ATE396732T1 (de) | Neue antivirale pharmazeutische zusammensetzung | |
| UY28575A1 (es) | Composiciones farmacéuticasa sólidas que comprende el ácido bis (e)-7-(4-(4-fluorfenil-6 -isopropil-2- (metil (metilsulfonil) amino) pirimidin- 5-il) -3r,5s)-3,5- dihidroxo- ............ | |
| WO2007004226A3 (en) | Compositions and methods for treatment of male erectile dysfunction (ed) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |